Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Pain 3Cachexia 3Breast Neoplasms 3Trigger Finger Disorder 2Prostatic Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Inflammation 2Ganglion Cysts 2De Quervain Disease 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatitis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Patient Satisfaction 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasm Metastasis 1Mucositis 1Menorrhagia 1

Interventions

Saline Solution 1Magnesium Sulfate 1Injections, Intravenous 1Ibuprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Supratentorial Brain Tumor × Ibuprofen × Clear all
NCT05763836 2023-03-10

Comparison of the Analgesic Effects of Scalp Nerve Block and Intravenous Ibuprofen Applications Under the Guidance of Nociception Level Index (NoL) in Patients Undergoing Elective Supratentorial Craniotomy

Ankara University

Phase 4 Unknown
102 enrolled

Supratentorial Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡